Company profile: ElectroCore
1.1 - Company Overview
Company description
- Provider of neuromodulation therapies for the non-invasive treatment of diseases and disorders, including gammaCore and gammaCore Sapphire devices offering non-invasive vagus nerve stimulation for migraine and cluster headache treatment; Truvaga, a natural solution designed to enhance mental clarity and overall health; and TAC-STIM, a portable device aimed at the military for vagus nerve stimulation with quick administration and long-lasting benefits.
Products and services
- GammaCore Sapphire: An updated version of the gammaCore device engineered by ElectroCore, offering non-invasive vagus nerve stimulation for headache treatment
- GammaCore: A non-invasive vagus nerve stimulator engineered by ElectroCore for the treatment of migraine and cluster headaches
- TAC-STIM: A portable device engineered by ElectroCore aimed at the military for vagus nerve stimulation with quick administration and long-lasting benefits
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to ElectroCore
Autonomix
HQ: United States
Website
- Description: Provider of catheter-based sensing and proprietary ablation technologies that detect, differentiate, and target peripheral neural signals to treat pain or disease, offering an alternative to systemic drugs or blind approaches. Includes a catheter-deployed microchip with basket design converting analog to digital and first-in-class electrophysiology; initial focus on pancreatic cancer pain and minimally invasive renal denervation; supported by 15 patent families and 100+ patents.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Autonomix company profile →
Precision Neuroscience
HQ: United States
Website
- Description: Provider of brain-computer interface technology, including the Layer 7 Cortical Interface, a minimally invasive, high-resolution implant for recording and stimulating brain activity; Precision BioMEMS microfabrication of biocompatible microelectrode arrays and foundry services; machine learning software to translate neural data; and a fast, reversible surgical implantation technique.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Precision Neuroscience company profile →
Caraway Therapeutics
HQ: United States
Website
- Description: Provider of precision small-molecule therapeutics for CNS and rare diseases, developing medicines that enhance cellular clearance by activating the lysosome to remove toxic materials and defective cellular components. Leverages modulation of mitophagy and autophagy to use natural clearance pathways, preventing cell damage and treating neurodegenerative disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Caraway Therapeutics company profile →
Eledon Pharmaceuticals
HQ: United States
Website
- Description: Provider of biotechnology therapies and clinical programs for organ and cellular transplantation, featuring tegoprubart, a therapeutic antibody to regulate immune response and prevent rejection. Offers the Phase 2 BESTOW kidney transplant trial, support resources for transplant patients, and R&D in ALS, xenotransplantation, and islet cell transplantation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Eledon Pharmaceuticals company profile →
Tissuemed
HQ: United Kingdom
Website
- Description: Provider of tissue-based therapeutic devices and surgical bioadhesive films, including the first tissue heart valve to gain regulatory approval in Europe. Specializes in adhesive films to prevent air, blood and fluid leaks encountered in surgery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tissuemed company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for ElectroCore
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to ElectroCore
2.2 - Growth funds investing in similar companies to ElectroCore
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for ElectroCore
4.2 - Public trading comparable groups for ElectroCore
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →